Prof. Dr. Hauh-Jyun Chen | Environmental Chemistry | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Hauh-Jyun Chen | Environmental Chemistry | Best Researcher Award

Prof. Dr. Hauh-Jyun Chen | Environmental Chemistry | Dept Chemistry and Biochemistry at National Chung Cheng University , Taiwan 

Dr. Hauh-Jyun Candy Chen is a Distinguished Professor in the Department of Chemistry and Biochemistry at National Chung Cheng University, Taiwan. She is a leading expert in organic chemistry, chemical carcinogenesis, and mass spectrometric analysis of biomolecules. Dr. Chen earned her Ph.D. in Organic Chemistry from the State University of New York at Stony Brook in 1988 under the supervision of Professor Iwao Ojima. Her research focuses on using mass spectrometry for biomarker identification in cancer and oxidative stress-related diseases. She has made significant contributions to understanding post-translational modifications in hemoglobin and DNA, particularly in relation to cigarette smoking and carcinogen exposure. Dr. Chen has held various academic and research positions in the U.S. and Taiwan, including at the American Health Foundation and the National Institutes of Health. She has published extensively in high-impact journals and is recognized internationally for her pioneering work in analytical toxicology.

Professional Profile : 

Orcid

Scopus  

Summary of Suitability for Award:

Professor Hauh-Jyun Candy Chen is an outstanding researcher in the field of organic chemistry and biochemical research, with a strong focus on mass spectrometry-based biomonitoring, chemical exposome analysis, and biomarker identification related to cancer and smoking-related diseases. Her academic credentials, extensive research experience, and significant scientific contributions make her a strong candidate for the “Best Researcher Award. “Professor Hauh -J yun Candy Chen’s distinguished career, pioneering research in biomolecular analysis, and commitment to scientific advancements in chemistry and biochemistry make her an exceptional candidate for the “Best Researcher Award.” Her work not only deepens the understanding of chemical exposures and their health effects but also has significant translational potential in clinical diagnostics and public health. Given her research impact, leadership in the field, and continuous contributions to high-quality publications, she is highly suitable for this prestigious recognition.

🎓Education:

Dr. Hauh-Jyun Candy Chen completed her Ph.D. in Organic Chemistry at the State University of New York at Stony Brook in 1988. Her dissertation, titled New and Effective Routes to Optically Pure Aromatic Amino Acids, Peptides, and Their Derivatives via Chiral β-Lactam Intermediates, was conducted under the guidance of Professor Iwao Ojima. She earned her Bachelor of Science degree in Chemistry from National Cheng Kung University, Taiwan, in 1983. Dr. Chen’s academic training provided her with a strong foundation in organic synthesis, bioanalytical chemistry, and mass spectrometry. Her interdisciplinary expertise has allowed her to develop innovative methodologies for studying chemical modifications in biomolecules, particularly in relation to disease biomarkers and environmental toxicology. Throughout her career, Dr. Chen has continuously expanded her research scope, integrating advanced analytical techniques to investigate the biochemical impacts of carcinogens, oxidative stress, and metabolic disorders.

🏢Work Experience:

Dr. Hauh-Jyun Candy Chen has over three decades of research and teaching experience in organic chemistry and bioanalytical sciences. She has been a Distinguished Professor at National Chung Cheng University since 2020, where she previously served as Professor (2004-2020), Associate Professor (1999-2004), and Assistant Professor (1997-1999). Before joining academia, she was an Associate Research Scientist at the American Health Foundation (1994-1997), where she worked on nucleic acid chemistry and chemical carcinogenesis. From 1992 to 1994, she was a Senior Research Fellow at the same institution. She also conducted postdoctoral research at the Rockefeller University (1989-1991), the Picower Institute for Medical Research (1991), and the National Institutes of Health (1988-1989). Her extensive research in analytical toxicology and mass spectrometry has advanced the understanding of oxidative and carcinogenic modifications in biomolecules, leading to breakthroughs in biomarker discovery for cancer and exposure assessment.

🏅Awards: 

Dr. Hauh-Jyun Candy Chen has received numerous awards and recognitions for her outstanding contributions to analytical chemistry and toxicology. Her research on post-translational modifications in hemoglobin and the development of mass spectrometric methodologies has been widely recognized. She has been invited to present at international conferences on biomolecular analysis and chemical carcinogenesis. Dr. Chen has received multiple research grants from prestigious funding agencies, reflecting the impact and significance of her work. Her publications in high-impact journals have garnered substantial citations, further establishing her as a leading figure in analytical toxicology. As a dedicated mentor, she has supervised numerous graduate students and postdoctoral researchers, many of whom have gone on to successful academic and industry careers. Her contributions to environmental health, biomarker discovery, and disease diagnostics continue to shape the field of chemical research and biomedical science.

🔬Research Focus:

Professor Hauh-Jyun Candy Chen’s research primarily focuses on the analysis of chemical exposures and their impact on human health using advanced mass spectrometry techniques. Her work emphasizes the identification and quantification of biomarkers for diseases linked to environmental and lifestyle factors, particularly in the context of cancer and smoking-related illnesses. A significant part of her research explores oxidative and post-translational modifications in proteins, such as hemoglobin, resulting from exposure to toxic chemicals like acrolein and malondialdehyde. Through high-resolution mass spectrometry, Professor Chen investigates how these modifications can serve as biomarkers for disease diagnosis and progression, particularly in cancer patients and smokers. Her research also includes studies on the chemical exposome, connecting environmental exposures to human health outcomes. With a focus on precision biomonitoring and toxicology, her work aims to improve disease prevention, early detection, and therapeutic strategies, providing valuable insights into the relationship between chemical exposures and chronic diseases.

Publication Top Notes:

Multiple Oxidative Modifications on Hemoglobin Are Elevated in Breast Cancer Patients as Measured by Nanoflow Liquid Chromatography-Tandem Mass Spectrometry

Authors: H.J.C. Chen, Hauh Jyun Candy; S. Hu, Shunxiang; C. Tu, Chiwen

Year: 2025

Citations: 0

Connecting Chemical Exposome to Human Health Using High-Resolution Mass Spectrometry-Based Biomonitoring: Recent Advances and Future Perspectives

Authors: Y. Chen, Yuanchieh; J.F. Hsu, Jing Fang; C. Chang, Chihwei; H.J.C. Chen, Hauh Jyun Candy; P. Liao, Pao-Chi

Year: 2023

Citations: 15

Response to “Malondialdehyde-Induced Post-Translational Modification of Human Hemoglobin”

Authors: H.J.C. Chen, Hauh Jyun Candy; Y. Liao, Yanling

Year: 2023

Citations: 0

Mass Spectrometry Analysis of DNA and Protein Adducts as Biomarkers in Human Exposure to Cigarette Smoking: Acrolein as an Example

Authors: H.J.C. Chen, Hauh Jyun Candy

Year: 2023

Citations: 15

Characterization and Quantification of Acrolein-Induced Modifications in Hemoglobin by Mass Spectrometry─Effect of Cigarette Smoking

Authors: H.J.C. Chen, Hauh Jyun Candy; S. Cheng, Shuwei; N. Chen, Naiying; D. Wu, Dengchyang

Year: 2022

Citations: 6

Malondialdehyde-Induced Post-translational Modifications in Hemoglobin of Smokers by NanoLC-NSI/MS/MS Analysis

Authors: H.J.C. Chen, Hauh Jyun Candy; C. Chen, Chauyi; Y. Fang, Yahsuan; K. Hung, Kaiwei; D. Wu, Dengchyang

Year: 2022

Citations: 10

 

 

Mr. Muhammad Ammad Jamil | Environmental Chemistry | Best Researcher Award

Posted on by sciencefather

Mr. Muhammad Ammad Jamil | Environmental Chemistry | Best Researcher Award

Mr. Muhammad Ammad Jamil , Bj Micro Lab, Pakistan

Muhammad Ammad Jamil is a dedicated researcher in biomedical sciences and biotechnology, with expertise in nanoparticles, biodiesel production, and cancer treatment. He holds an M.S. in Biomedical Sciences from the National University of Science and Technology (NUST), Islamabad, and a B.S. in Biotechnology from International Islamic University, Islamabad (IIUI). His research focuses on nano-coated drug formulations, cytotoxic activity, and microbial biotechnology. With experience as a Scientific Officer at Bj Micro Lab, and research roles at NUST and IIUI, he has contributed significantly to nanoparticles and biofuel development. He has also interned at Holy Family Hospital and Benazir Bhutto Hospital, gaining clinical laboratory experience. Muhammad has multiple research publications and certifications in industrial biotechnology, synthetic biology, and microbiology. His passion for scientific innovation, problem-solving, and biotechnology advancements positions him as a promising researcher in biomedical applications.

Professional Profile:

Orcid

Scopus  

Summary of Suitability for Award:

Muhammad Ammad Jamil is a highly promising researcher in biomedical sciences, nanotechnology, and biotechnology. His contributions to nanomedicine, biodiesel optimization, and cancer treatment research highlight his innovative approach to scientific advancements. With several research projects, including his work on metal nanoparticles enhancing Sorafenib drug efficacy against cancer cells, he has demonstrated strong expertise in nanotechnology-based therapeutics. His publications on biodiesel production, antibacterial nanoparticles, and cancer studies further reflect his diverse and impactful research portfolio. Muhammad Ammad Jamil’s groundbreaking research, technical expertise, and scientific contributions make him an excellent candidate for the Best Researcher Award. His strong academic background, hands-on research experience, and impactful publications position him as a leading researcher in biomedical and biotechnological sciences. With a focus on cancer nanomedicine, renewable energy, and microbial biotechnology, his work significantly contributes to scientific innovation and global healthcare advancements. His dedication, innovation, and research impact strongly justify his nomination for this prestigious award.

🎓Education:

Muhammad Ammad Jamil has pursued an excellent academic journey in biomedical sciences and biotechnology. He earned his M.S. in Biomedical Sciences (2022-2024) from the National University of Science and Technology (NUST), Islamabad, securing a CGPA of 3.45/4.00. His B.S. in Biotechnology (2018-2022) was completed at International Islamic University Islamabad (IIUI), with a CGPA of 3.72/4.00, reflecting his academic excellence. Prior to university, he completed his Intermediate (Pre-Medical) (2015-2017) at Punjab College of Science, Islamabad, and his Matriculation (Science) (2013-2015) from ASF Public School, Rawalpindi Cantt. His education has equipped him with expertise in cell culture, microbiology, molecular techniques (RT-PCR, ELISA), and data analysis. His strong foundation in biotechnology and biomedical sciences has led him to explore advanced research in nanotechnology-based drug delivery and biofuel optimization, making significant contributions to the scientific community.

🏢Work Experience:

Muhammad Ammad Jamil has extensive experience in biomedical research, nanoparticles, biodiesel production, and pathology laboratory techniques. He worked as a Scientific Officer at Bj Micro Lab in Rawalpindi, focusing on nano-coated drug formulations and cytotoxicity testing. He contributed to NUST Islamabad’s research project (2023-2024) on metal nanoparticles enhancing Sorafenib drug activity for cancer treatment. His IIUI Islamabad research project (2021-2022) involved the optimization of biodiesel from non-edible seed oil, strengthening his expertise in renewable energy and nanotechnology. He completed internships at Holy Family Hospital (2022) and Benazir Bhutto Hospital (2021), gaining hands-on experience in microbiology, hematology, and pathology labs. His diverse research background highlights his ability to integrate biotechnology, nanoscience, and clinical applications, demonstrating strong leadership, laboratory proficiency, and scientific problem-solving skills.

🏅Awards: 

Muhammad Ammad Jamil has received several prestigious honors for his academic and research excellence. He actively participated in renowned international conferences such as the Annual Conference on Nanoparticles and Bio-Drugs and the International Conference on Bio-Entrepreneurship. He is a member of the American Society of Microbiology, reflecting his commitment to global scientific research. His research contributions earned recognition in renewable energy and biomedical sciences, particularly for his studies on biodiesel optimization and cancer treatment using metal nanoparticles. He has successfully completed specialized certifications in Industrial Biotechnology, Synthetic Biology, and Stem Cell Science, broadening his expertise in biomedical innovations. His webinar participation on COVID-19 and microbiology further showcases his dedication to staying updated with emerging scientific trends. With his contributions to nanomedicine, biodiesel technology, and microbiology, he is recognized as a promising researcher in biotechnology and biomedical sciences.

🔬Research Focus:

Muhammad Ammad Jamil’s research is centered on biomedical nanotechnology, renewable energy, and microbial biotechnology. His current work at NUST Islamabad explores the use of metal nanoparticles to enhance Sorafenib drug activity against cancer cell lines, contributing to nanomedicine and cancer therapeutics. He has also conducted research at IIUI Islamabad on biodiesel production from non-edible seed oils, focusing on eco-friendly fuel alternatives. His expertise in nanoparticles synthesis, cytotoxicity testing, and microbial culture techniques allows him to develop innovative nano-drug formulations. He is proficient in biotechnological techniques such as ELISA, RT-PCR, and microbial assays, which support his contributions to biomedical research and disease treatment. His interdisciplinary approach integrates nanoscience, microbiology, and renewable energy, making his research highly impactful in sustainable healthcare and energy solutions.

Publication Top Notes:

Antibacterial Potential of Sodium Alginate Nanoparticles: Synthesis & Characterization

Authors: Shamsa Aziz, Muhammad Ammad Jamil

Journal: Green Materials

DOI: 10.1680/jgrma.24.00127

Citations: As of now, there are no available citation counts for this publication.

Various Prospects of Biodiesel Production: Techniques and Challenges

Authors: Muhammad Ammad Jamil, Shamsa Aziz, Muhammad Salman Khalid

Type: Preprint

DOI: 10.20944/preprints202409.1068.v1

Citations: Preprints are typically not peer-reviewed and may not have citation data available.

Basal Cell Carcinoma

Authors: Muhammad Ammad Jamil

Type: Book Chapter in “Skin Cancer – Past, Present and Future”

DOI: 10.5772/intechopen.1004884

Citations: Citation data for book chapters may not be readily available.

Comparison of the Effects of Kinesio Taping and Rigid Taping in Knee Osteoarthritis

Authors: Muhammad Ammad Jamil

Type: Preprint

DOI: 10.21203/rs.3.rs-4757796/v1

Citations: As a recent preprint, citation data may not be available.

Production and Optimization Study of Biodiesel Produced from Non-Edible Seed Oil

Authors: Muhammad Ammad Jamil

Journal: Science and Technology for Energy Transition

DOI: 10.2516/stet/2024036

Citations: Citation data is currently unavailable for this publication.